Clinical trial
Teriparatide and Strontium Ranelate Head-To-Head Comparison Trial
NCT00239629 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00239629 |
|---|---|
| Title | Teriparatide and Strontium Ranelate Head-To-Head Comparison Trial |
| Official title | Differential Effects of Teriparatide and Strontium Ranelate on Bone Remodeling and Formation in Postmenopausal Women With Osteoporosis |
| Lead sponsor | Eli Lilly and Company, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Postmenopausal Osteoporosis |
| Intervention type | Drug, Procedure |
| Interventions | Teriparatide, Strontium ranelate, Transiliac bone biopsy |
| Enrollment | 73 |
| Start date | Sep 1, 2005 |
| Completion | Jan 1, 2007 |
| First posted | Oct 17, 2005 |
| Last update posted | Jun 12, 2007 |
| Countries | Czechia, Germany, Greece, Israel, Mexico, Spain |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: